2025
Detection of Hypertrophic Cardiomyopathy on Electrocardiogram Using Artificial Intelligence.
Hillis J, Bizzo B, Mercaldo S, Ghatak A, MacDonald A, Halle M, Schultz A, L'Italien E, Tam V, Bart N, Moura F, Awad A, Bargiela D, Dagen S, Toland D, Blood A, Gross D, Jering K, Lopes M, Marston N, Nauffal V, Dreyer K, Scirica B, Ho C. Detection of Hypertrophic Cardiomyopathy on Electrocardiogram Using Artificial Intelligence. Circulation Heart Failure 2025, e012667. PMID: 40365710, DOI: 10.1161/circheartfailure.124.012667.Peer-Reviewed Original ResearchHypertrophic cardiomyopathyDetection of hypertrophic cardiomyopathyAssociated with significant morbidityPredictive valueNegative predictive valueArea under the curvePositive predictive valueSudden cardiac deathSignificant morbidityChart reviewCardiac deathScreening electrocardiogramDiagnostic codesCardiac imagingClinical expertisePopulation prevalenceBinary outcomesCardiomyopathyElectrocardiogramDiagnosisImprove detectionPrevalenceElectrocardiogram features
2024
F96. ALCOHOL USE AND DEMENTIA IN DIVERSE POPULATIONS
Topiwala A, Levey D, Zhou H, Deak J, Adhikari K, Ebmeier K, Bell S, Burgess S, Nichols T, Gaziano M, Stein M, Gelernter J. F96. ALCOHOL USE AND DEMENTIA IN DIVERSE POPULATIONS. European Neuropsychopharmacology 2024, 87: 256-257. DOI: 10.1016/j.euroneuro.2024.08.507.Peer-Reviewed Original ResearchMillion Veteran ProgramDementia riskMendelian randomizationDementia casesAlcohol usePrevalence of alcohol use disordersImpact of alcohol useRandom-effects meta-analysisAlcohol use disorder prevalenceProspective cohort studyStandard deviation increaseObservational associationsUK BiobankVeteran ProgramLevels of drinkingPopulation prevalenceAlcohol consumptionAlcohol use disorderCohort studyDisorder prevalenceDementiaDependent drinkersDose-response relationshipGenetic associationLight drinkers
2022
Structure-guided insights into potential function of novel genetic variants in the malaria vaccine candidate PfRh5
Mangou K, Moore A, Thiam L, Ba A, Orfanó A, Desamours I, Ndegwa D, Goodwin J, Guo Y, Sheng Z, Patel S, Diallo F, Sene S, Pouye M, Faye A, Thiam A, Nunez V, Diagne C, Sadio B, Shapiro L, Faye O, Mbengue A, Bei A. Structure-guided insights into potential function of novel genetic variants in the malaria vaccine candidate PfRh5. Scientific Reports 2022, 12: 19403. PMID: 36371450, PMCID: PMC9653458, DOI: 10.1038/s41598-022-23929-9.Peer-Reviewed Original ResearchConceptsImmune evasionSingle nucleotide polymorphismsPopulation prevalenceVaccine-induced protective immunityP. falciparum positive samplesFalciparum positive samplesPlasmodium falciparum antigensMalaria vaccine candidateNovel single nucleotide polymorphismsInhibitory monoclonal antibodiesProtective immunityFalciparum antigensMalaria deathsEffective vaccineEfficacious vaccineVaccine candidatesPfRH5Infected individualsVaccine targetsMonoclonal antibodiesLow overall frequencyReceptor bindingNovel genetic variantsVaccineOverall frequencyPrevalence of Fanconi anemia gene mutations among men undergoing multigene germline testing for prostate cancer: Interim results from the EMPOWeR study.
Giri V, Gross L, Russo J, Shimada A, McNair C, Kelly W, Gomella L. Prevalence of Fanconi anemia gene mutations among men undergoing multigene germline testing for prostate cancer: Interim results from the EMPOWeR study. Journal Of Clinical Oncology 2022, 40: 188-188. DOI: 10.1200/jco.2022.40.6_suppl.188.Peer-Reviewed Original ResearchProstate cancerPrevalence of FAGermline testingEMPOWER studyMultigene testingMutation carriersMutation prevalencePopulation prevalenceExact testLimited prevalence dataGene mutationsLikely pathogenic mutationsFisher's exact testCancer risk genesClinical characteristicsGleason scoreMean ageClinical trialsPCa diagnosisFA genesFas gene mutationPrevalence ratesCancer managementPCa biologyFA pathway genes
2020
Empiric Recurrence Risk Estimates for Chronic Tic Disorders: Implications for Genetic Counseling
Heiman GA, Rispoli J, Seymour C, Leckman JF, King RA, Fernandez TV. Empiric Recurrence Risk Estimates for Chronic Tic Disorders: Implications for Genetic Counseling. Frontiers In Neurology 2020, 11: 770. PMID: 32849224, PMCID: PMC7432137, DOI: 10.3389/fneur.2020.00770.Peer-Reviewed Original ResearchChronic tic disorderRecurrence risk estimatesTic disordersRecurrence riskTourette's disorderRisk estimatesNeuropsychiatric disordersPopulation-based family studyGenetic counselingFirst-degree relativesQuality of lifeFamily studiesVocal ticsPopulation prevalenceFamilial recurrence riskSuch counselingGenetic testingDisordersRiskCounselingEmpiric recurrence riskGenetic variantsRange of risksHeterogeneous genetic architectureComorbidities
2018
Axial spondyloarthritis in the USA: diagnostic challenges and missed opportunities
Danve A, Deodhar A. Axial spondyloarthritis in the USA: diagnostic challenges and missed opportunities. Clinical Rheumatology 2018, 38: 625-634. PMID: 30588555, DOI: 10.1007/s10067-018-4397-3.Peer-Reviewed Original ResearchConceptsDiagnostic delayBack painAxial spondyloarthritisChronic inflammatory rheumatic diseasesPoor long-term outcomesInflammatory rheumatic diseasesChronic back painLong-term outcomesPrimary care physiciansPublic health initiativesQuality of lifeEarly referralPain clinicCare physiciansRheumatic diseasesAcute careSpA featuresPrimary careDiagnostic challengeSacroiliac jointSpinal functionPhysical therapyEarly diagnosisAxSpAPopulation prevalence
2017
Patent foramen ovale in patients with pulmonary embolism: A prognostic factor on CT pulmonary angiography?
Zhang M, Tan S, Patel V, Zalta B, Shmukler A, Levsky J, Jain V, Shaban N, Haramati L. Patent foramen ovale in patients with pulmonary embolism: A prognostic factor on CT pulmonary angiography? Journal Of Cardiovascular Computed Tomography 2017, 12: 271-274. PMID: 29217343, DOI: 10.1016/j.jcct.2017.11.009.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overComputed Tomography AngiographyEchocardiographyFemaleForamen Ovale, PatentHumansMaleMiddle AgedMultidetector Computed TomographyPredictive Value of TestsPrevalencePrognosisPulmonary ArteryPulmonary EmbolismReproducibility of ResultsRetrospective StudiesRisk FactorsTime FactorsYoung AdultConceptsAcute pulmonary embolismRight heart strainPulmonary embolismTransthoracic echocardiogramHeart strainPatent foramenRight ventricularCT pulmonaryCT signsExact testVentricular diameter ratioRoutine transthoracic echocardiogramFischer's exact testYears of experiencePFO prevalenceSeptal bowingPrognostic factorsContrast refluxRetrospective studyRisk factorsMedical CenterMAIN OUTCOMEPopulation prevalencePatientsAdvanced imaging
2015
Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331 288 participants
Danaei G, Fahimi S, Lu Y, Zhou B, Hajifathalian K, Di Cesare M, Lo W, Reis-Santos B, Cowan M, Shaw J, Bentham J, Lin J, Bixby H, Magliano D, Bovet P, Miranda J, Khang Y, Stevens G, Riley L, Ali M, Ezzati M, Abdeen Z, Kadir K, Abu-Rmeileh M, Acosta-Cazares B, Aekplakorn W, Aguilar-Salinas C, Ahmadvand A, Al Nsour M, Alkerwi A, Amouyel P, Andersen L, Anderssen S, Andrade D, Anjana R, Aounallah-Skhiri H, Aris T, Arlappa N, Arveiler D, Assah F, Avdicová M, Balakrishna N, Bandosz P, Barbagallo C, Barceló A, Batieha A, Baur L, Ben Romdhane H, Bernabe-Ortiz A, Bhargava S, Bi Y, Bjerregaard P, Björkelund C, Blake M, Blokstra A, Bo S, Boehm B, Boissonnet C, Bovet P, Brajkovich I, Breckenkamp J, Brewster L, Brian G, Bruno G, Bugge A, Cabrera de León A, Can G, Cândido A, Capuano V, Carvalho M, Casanueva F, Caserta C, Castetbon K, Chamukuttan S, Chaturvedi N, Chen C, Chen F, Chen S, Cheng C, Chetrit A, Chiou S, Cho Y, Chudek J, Cifkova R, Claessens F, Concin H, Cooper C, Cooper R, Costanzo S, Cottel D, Cowell C, Crujeiras A, D'Arrigo G, Dallongeville J, Dankner R, Dauchet L, de Gaetano G, De Henauw S, Deepa M, Dehghan A, Dhana K, Di Castelnuovo A, Djalalinia S, Doua K, Drygas W, Du Y, Egbagbe E, Eggertsen R, El Ati J, Elosua R, Erasmus R, Erem C, Ergor G, Eriksen L, Escobedo-de la Peña J, Fall C, Farzadfar F, Felix-Redondo F, Ferguson T, Fernández-Bergés D, Ferrari M, Ferreccio C, Finn J, Föger B, Foo L, Fouad H, Francis D, Franco Mdo C, Frontera G, Furusawa T, Gaciong Z, Galbarczyk A, Garnett S, Gaspoz J, Gasull M, Gates L, Geleijnse J, Ghasemain A, Giampaoli S, Gianfagna F, Giovannelli J, Gonzalez Gross M, González Rivas J, Gorbea M, Gottrand F, Grant J, Grodzicki T, Grøntved A, Gruden G, Gu D, Guan O, Guerrero R, Guessous I, Guimaraes A, Gutierrez L, Hardy R, Hari Kumar R, Heidemann C, Hihtaniemi I, Ho S, Ho S, Hofman A, Horimoto A, Hormiga C, Horta B, Houti L, Hussieni A, Huybrechts I, Hwalla N, Iacoviello L, Iannone A, Ibrahim M, Ikeda N, Ikram M, Irazola V, Islam M, Iwasaki M, Jacobs J, Jafar T, Jasienska G, Jiang C, Jonas J, Joshi P, Kafatos A, Kalter-Leibovici O, Kasaeian A, Katz J, Kaur P, Kavousi M, Kelishadi R, Kengne A, Kersting M, Khader Y, Khang Y, Kiechl S, Kim J, Kiyohara Y, Kolsteren P, Korrovits P, Koskinen S, Kratzer W, Kromhout D, Kula K, Kurjata P, Kyobutungi C, Lachat C, Laid Y, Lam T, Lanska V, Lappas G, Laxmaiah A, Leclercq C, Lee J, Lee J, Lehtimäki T, Lekhraj R, León-Muñoz L, Li Y, Lim W, Lima-Costa M, Lin H, Lin X, Lissner L, Lorbeer R, Lozano J, Lundqvist A, Lytsy P, Ma G, Machado-Coelho G, Machi S, Maggi S, Magliano D, Makdisse M, Mallikharjuna v K, Manios Y, Manzato E, Margozzini P, Marques-Vidal P, Martorell R, Masoodi S, Matsha T, Mbanya J, McFarlane S, McGarvey S, McLachlan S, McNulty B, Mediene-Benchekor S, Meirhaeghe A, Menezes A, Merat S, Meshram I, Mi J, Miquel J, Miranda J, Mohamed M, Mohammad K, Mohan V, Mohd Yusoff M, Møller N, Molnar D, Mondo C, Moreno L, Morgan K, Moschonis G, Mossakowska M, Mostafa A, Mota J, Muiesan M, Müller-Nurasyid M, Mursu J, Nagel G, Námešná J, Nang E, Nangia V, Navarrete-Muñoz E, Ndiaye N, Nervi F, Nguyen N, Nieto-Martínez R, Alvarado L, Ning G, Ninomiya T, Noale M, Noto D, Ochoa-Avilés M, Oh K, Onat A, Osmond C, Otero J, Palmieri L, Panda-Jonas S, Panza F, Parsaeian M, Peixoto S, Pereira A, Peters A, Peykari N, Pilav A, Pitakaka F, Piwonska A, Piwonski J, Plans-Rubió P, Porta M, Portegies M, Poustchi H, Pradeepa R, Price J, Punab M, Qasrawi R, Qorbani M, Raitakari O, Ramachandra Rao S, Ramachandran A, Ramos R, Rampal S, Rathmann W, Redon J, Reganit P, Rigo F, Robinson S, Robitaille C, Rodríguez L, Rodríguez-Artalejo F, del Cristo Rodriguez-Perez M, Rojas-Martinez R, Romaguera D, Rosengren A, Rubinstein A, Rui O, Ruiz-Betancourt B, Rutkowski M, Sabanayagam C, Sachdev H, Saidi O, Sakarya S, Salanave B, Salonen J, Salvetti M, Sánchez-Abanto J, Santos R, Santos R, Sardinha L, Scazufca M, Schargrodsky H, Scheidt-Nave C, Shaw J, Shibuya K, Shin Y, Shiri R, Siantar R, Sibai A, Simon M, Simons J, Simons L, Sjostrom M, Slowikowska-Hilczer J, Slusarczyk P, Smeeth L, Snijder M, Solfrizzi V, Sonestedt E, Soumare A, Staessen J, Steene-Johannessen J, Stehle P, Stein A, Stessman J, Stöckl D, Stokwiszewski J, Strufaldi M, Sun C, Sundström J, Suriyawongpaisal P, Sy R, Tai E, Tarawneh M, Tarqui-Mamani C, Thijs L, Tolstrup J, Topbas M, Torrent M, Traissac P, Trinh O, Tulloch-Reid M, Tuomainen T, Turley M, Tzourio C, Ueda P, Ukoli F, Ulmer H, Valdivia G, van Valkengoed I, Vanderschueren D, Vanuzzo D, Vega T, Velasquez-Melendez G, Veronesi G, Verschuren M, Vioque J, Virtanen J, Visvikis-Siest S, Viswanathan B, Vollenweider P, Voutilainen S, Wade A, Wagner A, Walton J, Mohamud W, Wang M, Wang Y, Wannamethee S, Weerasekera D, Whincup P, Widhalm K, Wiecek A, Wilks R, Willeit J, Wojtyniak B, Wong T, Woo J, Woodward M, Wu A, Wu F, Wu S, Xu H, Yang X, Ye X, Yoshihara A, Younger-Coleman N, Zambon S, Zargar A, Zdrojewski T, Zhao W, Zheng Y. Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331 288 participants. The Lancet Diabetes & Endocrinology 2015, 3: 624-637. PMID: 26109024, PMCID: PMC4673089, DOI: 10.1016/s2213-8587(15)00129-1.Peer-Reviewed Original ResearchConceptsHealth Examination SurveyPopulation prevalenceDiabetes prevalenceExamination SurveyPooled analysisPlasma glucoseUndiagnosed individualsOral glucose tolerance testDifferent biomarkersDifferent diagnostic definitionsPrevalence of diabetesPopulation-based studyGlucose tolerance testStudy-level characteristicsRandom-effects modelSimilar prevalence estimatesComplex survey designPrevious diagnosisUndiagnosed peopleTolerance testUS National InstitutesDiabetes definitionSources of heterogeneityHealth SurveyDifferent prevalence levels
2008
Estimates of HIV prevalence in a highly endemic area of China: Dehong Prefecture, Yunnan Province
Jia Y, Sun J, Fan L, Song D, Tian S, Yang Y, Jia M, Lu L, Sun X, Zhang S, Kulczycki A, Vermund SH. Estimates of HIV prevalence in a highly endemic area of China: Dehong Prefecture, Yunnan Province. International Journal Of Epidemiology 2008, 37: 1287-1296. PMID: 18922804, PMCID: PMC2638873, DOI: 10.1093/ije/dyn196.Peer-Reviewed Original ResearchConceptsHIV prevalenceDehong PrefectureCurrent HIV preventionInjection drug useInjection drug usersFemale sex workersHIV/AIDS epidemicHIV/AIDSHIV infectionHIV preventionTreatment challengesClinical dataEndemic areasHIV problemPopulation prevalenceDrug usersDrug usePrevalenceAIDS epidemicWorkbook methodEpidemic patternsSex workersInfectionMillion peopleUneven geographical distribution
1989
ESTIMATING POPULATION PREVALENCE OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN URBAN AREAS WITH HIGH RATES OF INTRAVENOUS DRUG USE: A MODEL OF THE BRONX IN 1988
DRUCKER E, VERMUND S. ESTIMATING POPULATION PREVALENCE OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN URBAN AREAS WITH HIGH RATES OF INTRAVENOUS DRUG USE: A MODEL OF THE BRONX IN 1988. American Journal Of Epidemiology 1989, 130: 133-142. PMID: 2787104, DOI: 10.1093/oxfordjournals.aje.a115304.Peer-Reviewed Original ResearchConceptsIntravenous drug usersDrug usersAIDS casesIntravenous drug-using populationHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionIntravenous drug useHuman immunodeficiency virusAge group 25HIV prevalence estimatesAge 13 yearsDrug-using populationsHIV seroprevalenceImmunodeficiency syndromeAIDS patientsImmunodeficiency virusRisk factorsVirus infectionUse populationGroup 25Seroprevalence rangesPopulation prevalencePrevalence estimatesDrug useHigh rate
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply